Pharmacotherapy for overactive bladder: minimally invasive treatment –– botulinum toxins

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.7, 2011-05, pp. : 1029-1039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacotherapy of overactive bladder

By Athanasopoulos Anastasios

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1003-1005

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder

By Latini Jerilyn M Giannantoni Antonella

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1017-1027

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano Serati Maurizio Bolis Pierfrancesco

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Imidafenacin for the treatment of overactive bladder

By Leone Roberti Maggiore Umberto Scala Carolina Venturini Pier Luigi Ferrero Simone

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1383-1397

Informa Healthcare

Access to resources Recommend Favorite

Mirabegron in the treatment of overactive bladder

By Leone Roberti Maggiore Umberto Cardozo Linda Ferrero Simone Sileo Filomena Cola Alice Torella Marco Colacurci Nicola Candiani Massimo Salvatore Stefano

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite